• Chenodeoxycholic Acid: Reliable FXR Assays

  2026-08-23

  Learn how Chenodeoxycholic Acid (SKU B1908) can support reproducible FXR, viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers solubility, vehicle controls, protocol design, mechanistic interpretation, and practical vendor selection.

• CCT007093: From PPM1D to p38 Signal Logic

  2026-08-22

  Explore how CCT007093, a PPM1D inhibitor, converts phosphatase control into measurable p38 signaling and cell-death phenotypes. This article emphasizes causal assay design across breast cancer and kidney-injury models rather than repeating a conventional workflow.

• Nigericin Sodium Salt in Cancer Drug Assays

  2026-08-22

  Use Nigericin sodium salt as a controlled potassium ionophore to probe how ion gradients and cytoplasmic pH influence cell-state measurements. A workflow that pairs this perturbation with separate proliferation and cell-killing readouts can reveal drug-response differences hidden by a single viability endpoint.

• Polymyxin B: LPS Biology for Better Assays

  2026-08-21

  Polymyxin B sulfate is more than a membrane-active antibiotic: it is a powerful experimental perturbation for linking bacterial viability, LPS structure, and innate immune signaling. This guide explains how to use it rigorously in Gram-negative infection research and interpret results alongside microbiome-driven immunotherapy findings.

• From Glucose Uptake to Hepatic Insulin Resistance

  2026-08-20

  A mechanistic framework for using glucose uptake measurements to investigate how the Galectin-1–FIP200 axis links impaired autophagy with hepatic steatosis and insulin resistance. The article explains how the WST-8 Glucose Uptake Assay Kit can support translational studies while highlighting essential controls, interpretation limits, and opportunities for model development.

• Dextromethorphan Hydrobromide in Neuroprotection

  2026-08-20

  Dextromethorphan hydrobromide is an NMDA receptor antagonist for dissecting excitotoxicity, ion-channel signaling, and neuroprotection. This guide adds an assay-design perspective, showing how to distinguish direct channel effects from downstream protection and how to interpret evidence across disease models.

• Miltefosine Activates Ras/MEK/ERK in Leukopenia

  2026-08-19

  The reference study identifies Miltefosine as a small-molecule strategy for leukopenia that promotes neutrophil differentiation and restores myelopoiesis after irradiation. Its combination of cell-based assays, a murine model, transcriptomics, network pharmacology, molecular docking, and ERK inhibition supports the Ras/MEK/ERK cascade as a central mechanism, while leaving clinical translation and pathway selectivity for future work.

• Withania somnifera Digestion: LC–MS/MS Insights

  2026-08-19

  A 2026 study combined simulated gastrointestinal digestion, LC–MS/MS, molecular networking, and untargeted metabolomics to determine how Withania somnifera leaf and root extracts change before absorption. Withaferin A and withanoside IV were transformation-prone, whereas withanolide A was comparatively stable, highlighting the importance of digestive stability in botanical pharmacokinetic research.

• ZCL278: Selective Cdc42 Inhibitor Guide

  2026-08-18

  ZCL278 is a selective Cdc42 inhibitor with a reported Kd of 11.4 μM and activity in cancer, neuronal, and fibroblast models. Its strongest use is mechanistic interrogation of Cdc42-dependent cell motility, neuronal morphology, and GTPase signaling rather than clinical treatment.

• Salvianolic Acid B, LH2, and Pulmonary Fibrosis

  2026-08-18

  The reference study identifies Salvianolic acid B, also known as Dan Shen Suan B, as a natural product that reduces pulmonary fibrosis-associated collagen remodeling by lowering LH2/PLOD2 expression. Its experiments connect LH2 suppression with reduced collagen deposition, epithelial–mesenchymal transition, fibroblast activation, and Wnt/β-catenin signaling, providing a mechanistic basis for extracellular matrix-focused research.

• Verteporfin (CL 318952) for Reliable Cell Assays

  2026-08-17

  This scenario-driven guide explains how Verteporfin (SKU A8327) can improve the interpretation of viability, proliferation, cytotoxicity, apoptosis, and autophagy experiments. It provides practical controls for light activation, DMSO handling, concentration selection, and vendor evaluation.

• 10 mM dNTP Mixture: Assay-Ready DNA Synthesis

  2026-08-17

  The 10 mM dNTP mixture is an equimolar DNA synthesis reagent for PCR, qPCR, sequencing, and polymerase-based assays. This guide goes beyond routine reagent selection by showing how controlled nucleotide inputs can strengthen assay interpretation while clarifying their boundaries in lipid nanoparticle research.

• Polymyxin B Sulfate: Research Workflows

  2026-08-16

  Build reproducible membrane-disruption, immune-signaling, and Gram-negative infection assays with Polymyxin B sulfate. This guide connects isolate testing and sepsis models with a practical microbiome-aware framework inspired by recent allergic-rhinitis research.

• Salvianolic acid B: Reliable Fibrosis Assays

  2026-08-15

  Learn how Salvianolic acid B, SKU N1806, can help laboratories separate cytotoxicity from antifibrotic activity in viability, proliferation, and extracellular matrix assays. This scenario-based guide covers assay compatibility, protocol optimization, interpretation, and practical product-selection criteria.

• DFO: A Smarter Workflow for Latent Prints

  2026-08-14

  DFO (9H-1,8-Diazafluoren-9-one) is more than a fluorescent dye for fingerprint detection: it is a substrate-aware analytical tool. This guide explains its chemistry, handling, workflow decisions, and the assay-design lessons that can be drawn from contemporary mechanistic research.

3640 records 1/243 page Next 12345 下5页 Last page